Analyst Reco. Anterix Inc.

Equities

ATEX

US03676C1009

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
32.21 ^USD	+1.00%		+1.54%	-3.33%

05/03	Transcript : Anterix Inc. Presents at Morgan Stanley?s Technology, Media & Telecom Conference 2024, Mar-05-2024 02:05 PM
15/02	Transcript : Anterix Inc., Q3 2024 Earnings Call, Feb 15, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Adjusts Price Target on Anterix to $41 From $42, Maintains Equal-Weight Rating	01/23/01	MT
Morgan Stanley Adjusts Price Target on Anterix to $42 From $63, Maintains Equal-Weight Rating	24/23/24	MT
Morgan Stanley Adjusts Anterix's Price Target to $63 from $65, Maintains Equalweight Rating	10/22/10	MT
Berenberg and Goldman Sachs German Corporate Conference	21/21/21	FA
ANTERIX : Morgan Stanley Adjusts Price Target on Anterix to $65 From $51, Maintains Equal-Weight Rating	04/21/04	MT
ANTERIX : JPMorgan Adjusts Price Target on Anterix to $60 From $50, Maintains Overweight Rating	17/21/17	MT
ANTERIX : Morgan Stanley Adjusts Price Target on Anterix to $51 From $48, Maintains Equal-Weight Rating	09/21/09	MT
ANTERIX : JPMorgan Upgrades Anterix to Overweight From Neutral, Adjusts Price Target to $50 From $40	17/21/17	MT
ANTERIX : JPMorgan Upgrades Anterix to Neutral From Underweight, Adjusts Price Target to $40 From $30	01/21/01	MT
ANTERIX : Morgan Stanley Adjusts Price Target on Anterix to $48 From $50, Maintains Equal-Weight Rating	27/21/27	MT
ANTERIX : JP Morgan Downgrades Anterix to Underweight from Neutral, Lowers PT to $30 From $58	18/20/18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer